Men's Health News

RSS

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today the creation of TocopheRx, a Boston-based spin-off company resulting from the Entrepreneur Partnership Program launched by Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, in April 2012.

3 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

World's first clinical trial to use MLC tracking system to improve prostate cancer radiotherapy treatment

Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.

28 Nov 2013

NX Direct raise funds for Movember Foundation dedicated to promote men's health awareness

NX Direct, a privately-owned sales and marketing company, announced that they helped host a successful fundraiser at the Tin Roof Cantina to raise funds for men's health awareness. Called the "Stache Bash" and complete with giveaways and mustache karaoke, the event raised over $1,000 in a single evening for the Movember Foundation.

27 Nov 2013

Breakthrough discovery could lead to development of future therapeutics for prostate cancer

Drs. Andrew Goldstein, Owen Witte, and Tanya Stoyanova and their colleagues from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have found that prostate cancer can develop in one type of stem cell, then evolve to be maintained by a stem cell that looks very different, making prostate cancer stem cells a "moving target" for treatments. The breakthrough discovery connects directly to the development of future therapeutics that target cancer and was published online ahead of print in the Proceedings of the National Academy of Sciences.

27 Nov 2013

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Nutranomics, Inc. is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC to acquire the worldwide exclusive marketing and distributing rights to GenEpic, a natural therapeutic treatment formula currently the subject of an IRB reviewed phase II human clinical study on prostate cancer treatment and recovery.

25 Nov 2013

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.

25 Nov 2013

Unemployed men show signs of faster ageing in their DNA

Men who are unemployed for more than two years show signs of faster ageing in their DNA, a new study has found.

21 Nov 2013

Researchers associate some insomnia symptoms with higher mortality risk in men

Insomnia, the most common sleep disorder, affects up to one-third of the population in the United States. In new findings, researchers from Brigham and Women's Hospital have found that some insomnia symptoms are associated with an increased risk of mortality in men.

20 Nov 2013

Study on injuries to the ureter during robotic prostatectomy

There may be warning signs to help surgeons avoid damaging part of the urinary system during robot-assisted surgical removal of prostate cancer, ultimately preventing the expense of additional surgery, according to researchers at Henry Ford's Vattikuti Urology Institute.

20 Nov 2013

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

An investigational prostate cancer treatment slows the disease's progression and may increase survival, especially among men whose cancer has spread to the bones, according an analysis led by the Duke Cancer Institute.

20 Nov 2013

Findings may help scientists better understand prognosis of advanced prostate cancer

Many patients diagnosed with prostate cancer have indolent, slow-growing forms of the disease that are not life-threatening. However, more than 30,000 American men will die from aggressive prostate cancer this year alone. This sharp contrast between low-risk and aggressive disease presents a challenge for many researchers and physicians as they diagnose patients and also determine the prognosis of the men with the most aggressive forms of prostate cancer.

19 Nov 2013

CCP scores lower in prostate cancer patients who consume low-fat fish oil diet

Men with prostate cancer who ate a low-fat diet and took fish oil supplements had lower levels of pro-inflammatory substances in their blood and a lower cell cycle progression score, a measure used to predict cancer recurrence, than men who ate a typical Western diet, UCLA researchers found.

19 Nov 2013

Oxford scientists use nanoparticles to study mechanisms underlying 'mystery' cases of infertility

A way of using nanoparticles to investigate the mechanisms underlying 'mystery' cases of infertility has been developed by scientists at Oxford University.

18 Nov 2013

Treatment of pelvic nodes can be easily integrated into IMRT-based treatment strategy

Treatment of pelvic nodes individualized by inclusion of sentinel nodes can be easily integrated into an IMRT-based treatment strategy, according to the new study conducted by a group of researchers from T-bingen and Munich in Germany. The target volume concept seems to correctly cover individual pelvic nodes, which is indicated by the absence of any nodal recurrence within five years of follow-up.

18 Nov 2013

Quantitative models predict risk of acute urinary symptoms in prostate cancer patients treated with RT

An interim study by Italian researchers showed that using a modelling programme together with IPSS and dosage measure can predict the severity of acute urinary symptoms in patients with early prostate cancer who underwent radiotherapy.

16 Nov 2013

Study suggests novel approach for treatment of advanced metastatic prostate cancers

New study suggests that selective blockade of CRM1-dependent nuclear export represents a completely novel, tumour metastasis-selective approach for the treatment of advanced metastatic prostate cancers.

16 Nov 2013

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo (radium Ra 223 dichloride) solution for injection for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. This decision follows a positive recommendation from the European Committee for Medicinal Products for Human Use in September of this year.

15 Nov 2013

Study shows that geranylgeraniol suppresses viability of human DU145 prostate carcinoma cells

Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis.

14 Nov 2013

African American men have higher risk of developing prostate cancer than European American men

African American men have a 60 percent higher risk of developing prostate cancer than European American men, and a 2.4 times higher risk of dying from the disease. Some of the reasons can be attributed to differences in screening practices and treatment, but further research is needed to determine more explicit explanations.

14 Nov 2013

Men's Health News

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

New biomarkers to improve diagnostics of prostate cancer

World's first clinical trial to use MLC tracking system to improve prostate cancer radiotherapy treatment

NX Direct raise funds for Movember Foundation dedicated to promote men's health awareness

Breakthrough discovery could lead to development of future therapeutics for prostate cancer

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

Unemployed men show signs of faster ageing in their DNA

Researchers associate some insomnia symptoms with higher mortality risk in men

Study on injuries to the ureter during robotic prostatectomy

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

Findings may help scientists better understand prognosis of advanced prostate cancer

CCP scores lower in prostate cancer patients who consume low-fat fish oil diet

Oxford scientists use nanoparticles to study mechanisms underlying 'mystery' cases of infertility

Treatment of pelvic nodes can be easily integrated into IMRT-based treatment strategy

Quantitative models predict risk of acute urinary symptoms in prostate cancer patients treated with RT

Study suggests novel approach for treatment of advanced metastatic prostate cancers

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

Study shows that geranylgeraniol suppresses viability of human DU145 prostate carcinoma cells

African American men have higher risk of developing prostate cancer than European American men

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News